Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06397651 · ClinicalTrials.gov registry record · NA

A Randomised Controlled Trial to Evaluate the Impact of Complement Theory's Live CoActive Exercise Coaching and Personalized Digital Application on Cancer Survivors' Quality of Life

A NA study of Breast Cancer and Prostate Cancer, sponsored by Complement Theory.

Active
Registry status
NA
Development phase
146
Enrollment target
1
Study location

NCT06397651: Active NA study of Breast Cancer and Prostate Cancer, sponsored by Complement Theory.

NCT06397651 is a NA study of Breast Cancer and Prostate Cancer that is active but no longer recruiting, run by Complement Theory. The registered enrollment target is 146 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06397651, a NA study of Breast Cancer and Prostate Cancer, is active but no longer recruiting, sponsored by Complement Theory.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
146 participants
Enrollment target
1
Study location

Study Summary

A Decentralized, Double-blinded, Randomized, 18 month, Parallel-group, Superiority Study to evaluate the impact of Complement Theory's Live Coactive Exercise Coaching and Personalized Digital Application on Cancer Survivors' Quality of Life

Primary Outcome

To quantify the impact of Complement Theory's Program on cancer survivors' Quality of Life, as measured by the change in FACT-G scores over the course of the trial.

Interventions

  • BEHAVIORAL Complement Theory's Live CoActive Exercise Coaching and Personalized Digital Application
  • BEHAVIORAL Digital application with expert guidelines on lifestyle modification

Study Locations (1)

Delaware

  • Complement Theory Inc. - Dover

Trial Details

FieldValue
Enrollment Target 146 participants
Start Date 2024-05-12
Est. Completion 2026-02-28
Phase NA
Complement Theory

1 total trials

What the registry record for NCT06397651 still lists

NCT06397651 is an interventional study that assigns participants to a tested intervention. The registered 146 participants enrollment target is mid-sized for trials with a published cap, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (95% lower).

The record links to 5 conditions, with Breast Cancer appearing as the primary indexed condition, and to 2 interventions - of which Complement Theory's Live CoActive Exercise Coaching and Personalized Digital Application is the first listed.

NCT06397651 reports a single indexed study location in Delaware.

Frequently Asked Questions

What is clinical trial NCT06397651 about?

NCT06397651 is a clinical study titled "A Randomised Controlled Trial to Evaluate the Impact of Complement Theory's Live CoActive Exercise Coaching and Personalized Digital Application on Cancer Survivors' Quality of Life". A Decentralized, Double-blinded, Randomized, 18 month, Parallel-group, Superiority Study to evaluate the impact of Complement Theory's Live Coactive Exercise Coaching and Personalized Digital Application on Cancer Survivors' Quality of Life

What is the current status of trial NCT06397651?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 146 participants. The study started on 2024-05-12. Estimated completion is 2026-02-28.

What conditions does trial NCT06397651 study?

This clinical trial studies the following conditions: Breast Cancer, Prostate Cancer, Lung Cancer, Colorectal Cancer, Other Cancer.

What interventions are being tested in trial NCT06397651?

The interventions under investigation include: Complement Theory's Live CoActive Exercise Coaching and Personalized Digital Application (BEHAVIORAL), Digital application with expert guidelines on lifestyle modification (BEHAVIORAL).

Who is sponsoring clinical trial NCT06397651?

This trial is sponsored by Complement Theory, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06397651 being conducted?

This trial has 1 study location across Delaware. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Breast Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06397651's enrollment target sits among peer trials

146 455th of 1224 higher than 770 of 1,224 other Breast Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Breast Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03490929 · 146 participants · Phase 4

    CEUS for Blunt Abdominal Trauma in Children

  • NCT04755062 · 146 participants · NA

    A Culturally-relevant Micronutrient-dense Plant-rich (mNDPR) Dietary Intervention for Native Americans

  • NCT04867954 · 146 participants

    Development of 4D Flow MRI for Risk Stratification of Variceal Bleeding in Cirrhosis

  • NCT05051618 · 146 participants · NA

    Exercise Training for Managing Major Depressive Disorder in Multiple Sclerosis

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06397651, the US trial registry maintained by the National Library of Medicine. NCT06397651 (mid enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.